Literature DB >> 17425195

Lymph node metastasis of soft tissue tumors: a cytomorphologic study.

Anand C Loya1, Aruna K Prayaga, Anu Arora, C Sundaram, I Satish Rao, Shantveer G Uppin, G Suryanarayana Raju, Anjna Surath, R Senthil Rajappa.   

Abstract

OBJECTIVE: To study the frequency of regional lymph node metastasis of soft tissue tumors (STT) and to evaluate the utility of fine needle aspiration cytology (FNAC) as an initial investigative modality. STUDY
DESIGN: A prospective and retrospective study of over 6 years (1998-2004) was performed to look for frequency of STT metastasizing to lymph nodes. FNAC of enlarged nodes was performed as a routine outpatient procedure after obtaining complete clinical details. Histopathology and immunohistochemistry were correlated where available.
RESULTS: Lymph node enlargement was seen in 23 of 241 patients with STTs, of which 19 cases showed involvement (7.88%), synchronous with primary in 12 cases and metachronous in 7 cases. The most common sites of primary tumor were the lower extremity and head and neck region with involved regional lymph nodes. STTs commonly involving lymph nodes were rhabdomyosarcoma and extraskeletal Ewing's/primitive neuroectodermal tumor (PNET); other rare tumors included malignant granular cell tumor, epithelioid hemangioendothelioma, mediastinal ganglioneuroblastoma, angiosarcoma and epithelioid sarcoma.
CONCLUSION: Lymph node aspirates should be examined for alien cells, particularly smears that are paucicellular and demonstrate cystic change. Lymph node metastasis of STT is rare and influences staging, treatment and prognosis. Enlarged regional nodes should be examined with FNAC.

Entities:  

Mesh:

Year:  2007        PMID: 17425195     DOI: 10.1159/000325708

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  7 in total

Review 1.  Nodal metastases of soft tissue sarcomas: risk factors, imaging findings, and implications.

Authors:  Jeffrey Rosenthal; Kenneth Cardona; Samia K Sayyid; Adam J Perricone; Nickolas Reimer; David Monson; Adam Daniel Singer
Journal:  Skeletal Radiol       Date:  2019-08-23       Impact factor: 2.199

2.  Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.

Authors:  Andrew J Jacobs; Carol D Morris; Adam S Levin
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

Review 3.  [Radiotherapy of soft tissue sarcoma--part of a multidisciplinary strategy].

Authors:  Hildegard Pape; Klaus Orth; Rainer Engers; Christiane Matuschek; Anja Müller; Karl-Axel Hartmann; Peter Arne Gerber; Guido Lammering; Daniel Habermehl; Roland Fenk; Wilfried Budach; Stephan Gripp; Matthias Peiper; Edwin Bölke
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

4.  FNAC in the diagnosis of lymph node malignancies: A simple and sensitive tool.

Authors:  Anne R Wilkinson; Sadhana D Mahore; Sabiha A Maimoon
Journal:  Indian J Med Paediatr Oncol       Date:  2012-01

5.  A Machine Learning-Based Predictive Model for Predicting Lymph Node Metastasis in Patients With Ewing's Sarcoma.

Authors:  Wenle Li; Qian Zhou; Wencai Liu; Chan Xu; Zhi-Ri Tang; Shengtao Dong; Haosheng Wang; Wanying Li; Kai Zhang; Rong Li; Wenshi Zhang; Zhaohui Hu; Su Shibin; Qiang Liu; Sirui Kuang; Chengliang Yin
Journal:  Front Med (Lausanne)       Date:  2022-04-06

6.  Pan-Soft Tissue Sarcoma Analysis of the Incidence, Survival, and Metastasis: A Population-Based Study Focusing on Distant Metastasis and Lymph Node Metastasis.

Authors:  Haotian Liu; Hongliang Zhang; Chao Zhang; Zhichao Liao; Ting Li; Tielong Yang; Gengpu Zhang; Jilong Yang
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

7.  Scope of FNAC in the diagnosis of soft tissue tumors--a study from a tertiary cancer referral center in India.

Authors:  Bharat Rekhi; Biru D Gorad; Anagha C Kakade; Rf Chinoy
Journal:  Cytojournal       Date:  2007-10-31       Impact factor: 2.091

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.